DK2275815T3 - Forbedrede immunoassay-fremgangsmåder - Google Patents
Forbedrede immunoassay-fremgangsmåderInfo
- Publication number
- DK2275815T3 DK2275815T3 DK10180756.8T DK10180756T DK2275815T3 DK 2275815 T3 DK2275815 T3 DK 2275815T3 DK 10180756 T DK10180756 T DK 10180756T DK 2275815 T3 DK2275815 T3 DK 2275815T3
- Authority
- DK
- Denmark
- Prior art keywords
- immunoassay methods
- improved immunoassay
- antibody
- improved
- relats
- Prior art date
Links
- 238000003018 immunoassay Methods 0.000 title 1
- 238000003556 assay Methods 0.000 abstract 1
- 239000000090 biomarker Substances 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000022602 disease susceptibility Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
- G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68542205P | 2005-05-27 | 2005-05-27 | |
GB0510943A GB2426581A (en) | 2005-05-27 | 2005-05-27 | Immunoassay methods |
EP09004778A EP2073008B1 (en) | 2005-05-27 | 2006-05-26 | Improved immunoassay methods |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2275815T3 true DK2275815T3 (da) | 2014-05-12 |
Family
ID=34834805
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06744011T DK1889059T3 (da) | 2005-05-27 | 2006-05-26 | Fremgangsmåde til forbedret immunoassay |
DK09004778.8T DK2073008T3 (da) | 2005-05-27 | 2006-05-26 | Forbedrede immunoassayfremgangsmåder |
DK10180756.8T DK2275815T3 (da) | 2005-05-27 | 2006-05-26 | Forbedrede immunoassay-fremgangsmåder |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06744011T DK1889059T3 (da) | 2005-05-27 | 2006-05-26 | Fremgangsmåde til forbedret immunoassay |
DK09004778.8T DK2073008T3 (da) | 2005-05-27 | 2006-05-26 | Forbedrede immunoassayfremgangsmåder |
Country Status (19)
Country | Link |
---|---|
US (1) | US8722339B2 (da) |
EP (3) | EP2073008B1 (da) |
JP (1) | JP4876127B2 (da) |
KR (1) | KR101400986B1 (da) |
CN (2) | CN102749447B (da) |
AT (2) | ATE436018T1 (da) |
AU (1) | AU2006250923B2 (da) |
CA (1) | CA2609793C (da) |
DE (1) | DE602006007703D1 (da) |
DK (3) | DK1889059T3 (da) |
ES (3) | ES2328171T3 (da) |
GB (1) | GB2426581A (da) |
MX (1) | MX2007014815A (da) |
NO (1) | NO339224B1 (da) |
PL (2) | PL1889059T3 (da) |
PT (2) | PT2275815E (da) |
RU (1) | RU2416095C2 (da) |
SI (1) | SI2073008T1 (da) |
WO (1) | WO2006126008A2 (da) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6136311A (en) | 1996-05-06 | 2000-10-24 | Cornell Research Foundation, Inc. | Treatment and diagnosis of cancer |
GB9810040D0 (en) | 1998-05-11 | 1998-07-08 | Univ Nottingham | Blood borne tumour markers |
GB9827228D0 (en) * | 1998-12-10 | 1999-02-03 | Univ Nottingham | Cancer detection method and reagents |
US20030232399A1 (en) * | 2000-06-14 | 2003-12-18 | Robertson John Forsyth Russell | Cancer detection methods and reagents |
GB2424273B (en) | 2002-11-14 | 2007-06-27 | Univ Nottingham | Method for preparing tumour marker protein |
US7858323B2 (en) | 2004-06-09 | 2010-12-28 | The Regents Of The University Of Michigan | Phage microarray profiling of the humoral response to disease |
PT1889059E (pt) | 2005-05-27 | 2009-10-01 | Oncimmune Ltd | Métodos de imunoensaio melhorados |
GB2426581A (en) | 2005-05-27 | 2006-11-29 | Univ Nottingham | Immunoassay methods |
US9347945B2 (en) | 2005-12-22 | 2016-05-24 | Abbott Molecular Inc. | Methods and marker combinations for screening for predisposition to lung cancer |
ES2606015T3 (es) * | 2005-12-22 | 2017-03-17 | Abbott Molecular Inc. | Métodos y combinaciones de marcadores para la detección de la predisposición al cáncer de pulmón |
US8940871B2 (en) | 2006-03-20 | 2015-01-27 | The Regents Of The University Of California | Engineered anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting |
JP5495159B2 (ja) * | 2006-09-13 | 2014-05-21 | オンクイミューン リミテッド | 改善されたイムノアッセイ法 |
CN101632020B (zh) | 2006-09-13 | 2013-11-27 | 昂西免疫有限公司 | 改进的免疫测定方法 |
US20100015128A1 (en) * | 2006-10-03 | 2010-01-21 | University Of Southern California | GRP78 as a Predictor of Responsiveness to Therapeutic Agents |
EP2126562B1 (en) * | 2007-02-23 | 2014-12-31 | Physicians Choice Laboratory Services, LLC | Clinical intervention directed diagnostic methods |
WO2009032949A2 (en) | 2007-09-04 | 2009-03-12 | The Regents Of The University Of California | High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection |
AU2008329529B2 (en) | 2007-11-27 | 2015-02-19 | The University Of British Columbia | 14-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis |
GB0725239D0 (en) * | 2007-12-24 | 2008-02-06 | Oncimmune Ltd | Calibrator for autoantibody assay |
EP2252893B1 (en) * | 2008-02-21 | 2013-10-23 | Iris International, Inc. | Method for early determination of recurrence after therapy for prostate cancer |
WO2010033069A1 (en) | 2008-09-19 | 2010-03-25 | Ridgeview Instruments Ab | Method for the analysis of solid biological objects |
EP2389585A2 (en) * | 2009-01-22 | 2011-11-30 | Li-Cor, Inc. | Single molecule proteomics with dynamic probes |
ES2712732T3 (es) | 2009-02-17 | 2019-05-14 | Cornell Res Foundation Inc | Métodos y kits para el diagnóstico de cáncer y la predicción de valor terapéutico |
BRPI1009573A2 (pt) * | 2009-03-11 | 2017-07-18 | Augurex Life Sciences Corp | método para avaliar uma condição artrítica em um sujeito, kit para detectar a presença de um auto-anticorpo, e, método para determinar o subtipo de artrite em um paciente. |
SG176962A1 (en) * | 2009-06-23 | 2012-01-30 | Eventus Diagnostics Israel Ltd | A method and system for the detection of cancer |
CN101762700A (zh) * | 2009-06-24 | 2010-06-30 | 北京科美东雅生物技术有限公司 | 一种定量检测血液中癌胚抗原的磁性免疫层析试纸条及制备方法 |
AU2010275443B2 (en) | 2009-07-24 | 2016-05-12 | Rhode Island Hospital | Dendritic cell vaccines for asparaginyl- beta - hydroxylase expressing tumors |
CA3108458A1 (en) * | 2009-10-26 | 2011-05-12 | Societe Des Produits Nestle S.A. | Assays for the detection of anti-tnf drugs and autoantibodies |
EP3135302A1 (en) | 2009-12-02 | 2017-03-01 | Imaginab, Inc. | J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use |
EP2548025A4 (en) | 2010-03-17 | 2013-09-25 | Univ Michigan | USE OF PHOTOEPITOPES FOR PROFILING AN IMMUNE REACTION |
ES2534246T3 (es) | 2010-05-12 | 2015-04-21 | Hill's Pet Nutrition, Inc. | Métodos para el diagnóstico, control y profilaxis de la inflamación y mitigación de condiciones inflamatorias en los caninos |
US20130310266A1 (en) * | 2010-09-03 | 2013-11-21 | Immport Therapeutics, Inc. | Methods and Compositions For The Diagnosis And Treatment Of Cancer and Autoimmune Disorders |
KR101571940B1 (ko) * | 2010-10-08 | 2015-11-25 | 상하이 켁신 바이오테크 씨오., 엘티디. | 면역성 혈소판 감소증과 관련된 모에신 단편 |
EA018848B1 (ru) * | 2010-10-20 | 2013-11-29 | Вадим Юльевич ШАНИН | Иммунологически активное вещество, способ его получения, биозонд на его основе и способ диагностики состояния здоровья с применением биозонда, фармацевтическая композиция и способ лечения с использованием фармацевтической композиции |
CN102125698A (zh) * | 2010-11-29 | 2011-07-20 | 昆明理工大学 | 具有正常免疫功能的小鼠移植肿瘤模型的建立方法 |
WO2013006156A1 (en) | 2011-07-01 | 2013-01-10 | Inova Diagnostics, Inc. | Method for increasing specificity of diagnostic tests for autoimmune diseases |
WO2013056377A1 (en) | 2011-10-21 | 2013-04-25 | Augurex Life Sciences Corporation | Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis |
CN102590530B (zh) * | 2012-03-02 | 2014-06-25 | 常晓天 | Krt84自我免疫抗体作为诊断、检测类风湿性关节炎的诊断标记物的应用 |
WO2013163269A1 (en) * | 2012-04-24 | 2013-10-31 | Sri International | Human serum biomarkers of prostate cancer and sars-cov |
US20150362497A1 (en) * | 2013-01-31 | 2015-12-17 | Arizona Board of Regents on behalf of Arizona Stat State University | Autoantibody Signature for the Early Detection of Ovarian Cancer |
CN103604923B (zh) * | 2013-10-22 | 2015-05-13 | ***北京医院 | 检测抗甲状腺过氧化物酶和甲状腺球蛋白的天然双特异性抗体的试剂盒 |
DK3102600T3 (da) * | 2014-02-05 | 2019-04-01 | Fujirebio Diagnostics Ab | Sammensætning og fremgangsmåde til detektering af ondartet neoplastisk sygdom |
GB201411060D0 (en) * | 2014-06-20 | 2014-08-06 | Oncimmune Ltd | Improved immunoassay method |
CN104356226B (zh) * | 2014-11-04 | 2017-03-29 | 青岛海兰深生物科技有限公司 | 一种检测血浆免疫标志物‑vegfr1自身抗体的抗原多肽及应用 |
RU2765242C2 (ru) | 2015-08-07 | 2022-01-27 | Имаджинаб, Инк. | Антигенсвязывающие конструкции против молекул-мишеней |
CN113848322A (zh) * | 2015-12-11 | 2021-12-28 | 善福德健康 | 用于监测乳腺癌治疗的试剂和方法 |
CN106053812B (zh) * | 2016-06-29 | 2017-12-08 | 厦门生迪生物技术有限公司 | 一种用于肝癌早期筛查和诊断的多种自身抗体联合检测elisa试剂盒 |
JP6334017B1 (ja) * | 2017-01-25 | 2018-05-30 | ファナック株式会社 | 誘導電動機の制御装置 |
WO2018147960A1 (en) | 2017-02-08 | 2018-08-16 | Imaginab, Inc. | Extension sequences for diabodies |
JP2020524809A (ja) * | 2017-06-23 | 2020-08-20 | オンシミューン ジャーマニー ジーエムビーエイチ | がんを治療するためのがん免疫 |
CN111837038A (zh) * | 2018-02-01 | 2020-10-27 | 思迪亚生物科学公司 | 用于评估感染持续时间的快速定量分析 |
GB2600701A (en) | 2020-11-04 | 2022-05-11 | Oncimmune Ltd | Antibody assay |
US20230266331A1 (en) | 2020-07-14 | 2023-08-24 | Oncimmune Limited | Use of antigen combination for detecting autoantibodies in lung cancer |
CN112345755B (zh) * | 2020-09-23 | 2023-06-16 | 杭州凯保罗生物科技有限公司 | 乳腺癌的生物标志物及其应用 |
GB2622246A (en) | 2022-09-08 | 2024-03-13 | Oncimmune Germany Gmbh | Antibody assay |
Family Cites Families (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ211453A (en) | 1984-03-22 | 1989-01-06 | Biotechnology Research Enterpr | Aryl azides, their preparation and use in the detection, localisation and isolation of polynucleotides |
EP0236606B1 (en) | 1986-03-10 | 1992-06-24 | Imre Corporation | Immune complex assay |
US4925788A (en) * | 1986-10-24 | 1990-05-15 | Immunicon Corporation | Immunoassay system and procedure based on precipitin-like interaction between immune complex and Clq or other non-immunospecific factor |
WO1989001153A1 (en) | 1987-07-24 | 1989-02-09 | Xoma Corporation | Methods for breast cancer detection |
US4937185A (en) | 1987-07-31 | 1990-06-26 | The Ohio State University Research Foundation | Detection of circulating antibodies to a cancer marker protein |
US7282345B1 (en) | 1989-08-04 | 2007-10-16 | Schering Ag | C-erbB-2 external domain: GP75 |
US5157020A (en) | 1990-05-24 | 1992-10-20 | Research Corporation Tech., Inc. | Synthetic senescent cell antigen |
DK9091D0 (da) | 1991-01-18 | 1991-01-18 | Novo Nordisk As | Fremgangsmaade til fremstilling af antistoffer |
DE4120412C1 (da) * | 1991-06-20 | 1993-01-07 | Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin, De | |
US6280962B1 (en) | 1991-11-25 | 2001-08-28 | Yoreh Biotechnologies Ltd. | Whole blood/mitogen assay for the early detection of a subject with cancer and kit |
US6322989B1 (en) | 1991-11-25 | 2001-11-27 | Yoreh Biotechnologies, Ltd. | Whole blood/mitogen assay for the early detection of a subject with ovarian or breast cancer and kit |
ATE463573T1 (de) | 1991-12-02 | 2010-04-15 | Medimmune Ltd | Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken |
WO1993021529A1 (en) | 1992-04-14 | 1993-10-28 | Duke University | Method of detecting tumors containing complexes of p53 and hsp70 |
US5801005A (en) | 1993-03-17 | 1998-09-01 | University Of Washington | Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated |
US5763164A (en) | 1993-04-16 | 1998-06-09 | Northwestern University | Immunogenic cancer proteins and peptides and methods of use |
US5747268A (en) | 1993-04-22 | 1998-05-05 | Dade International Inc. | Tumor marker control |
CN1097252A (zh) * | 1993-07-03 | 1995-01-11 | 首钢总公司 | 多元同步标记分析法 |
US5744144A (en) | 1993-07-30 | 1998-04-28 | University Of Pittsburgh University Patent Committee Policy And Procedures | Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof |
US5721105A (en) | 1994-02-20 | 1998-02-24 | B.R.A.H.M.S. Diagnostica Gmbh | Method for the immunological determination of proteins and kit for carrying out the method |
JPH07294530A (ja) | 1994-04-20 | 1995-11-10 | Nippon Igaku Rinshiyou Kensa Kenkyusho:Kk | 病原体に対する体液中の抗体検出法 |
CA2148971A1 (en) | 1994-05-26 | 1995-11-27 | Izak Bahar | Calibrator matrix |
ES2150573T3 (es) | 1994-06-24 | 2000-12-01 | Vladimir P Torchilin | Composicion que contiene autoanticuerpos para la terapia y profilaxis tumorales. |
IL110464A0 (en) | 1994-07-26 | 1994-10-21 | Univ Ramot | Novel proteins for the diagnosis, imaging, and therapy of human cancer |
US5561049A (en) | 1994-09-21 | 1996-10-01 | Behringwerke Ag | Method for detecting antibodies |
US5876728A (en) | 1995-02-15 | 1999-03-02 | Howard David Kass | Natural composition extracted from plants used in the treatment of cancer |
AUPN568095A0 (en) | 1995-09-27 | 1995-10-26 | Austin Research Institute, The | Anti-Galalpha(1,3)Gal antibody binding peptides |
GB9521544D0 (en) | 1995-10-20 | 1995-12-20 | Univ Dundee | Activation of P53 protein and therapeutic applications thereof |
JPH09189702A (ja) | 1996-01-09 | 1997-07-22 | Hitachi Chem Co Ltd | 抗ムチン抗体の測定法、癌の測定法及び癌診断薬 |
ATE283069T1 (de) | 1996-08-16 | 2004-12-15 | Univ Johns Hopkins Med | Melanomzellinien, welche immundominante melanomantigene teilen und verfahren zu deren anwendung |
CN1044092C (zh) * | 1997-02-26 | 1999-07-14 | 上海医科大学 | 抗原-抗体-重组dna复合型疫苗 |
WO1998055872A1 (en) | 1997-06-03 | 1998-12-10 | Amdl, Inc. | Immunoassay for the detection of cancer |
DE19805815C1 (de) | 1998-02-13 | 1999-11-11 | Ansgar W Lohse | Diagnostikum zum Erkennen der autoimmunen Hepatitis |
JP4083855B2 (ja) | 1998-02-16 | 2008-04-30 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 肺癌予後検査方法 |
GB9810040D0 (en) | 1998-05-11 | 1998-07-08 | Univ Nottingham | Blood borne tumour markers |
AUPP349098A0 (en) | 1998-05-13 | 1998-06-04 | South Eastern Sydney Area Health Service | A method of monitoring pancreatic tissue viability |
IL142971A0 (en) | 1998-11-05 | 2002-04-21 | Univ Michigan | S100 proteins and autoantibodies as serum markers for cancer |
US6387639B1 (en) | 1998-11-10 | 2002-05-14 | Sloan-Kettering Institute For Cancer Research | Ma family polypeptides and anti-Ma antibodies |
GB9827228D0 (en) | 1998-12-10 | 1999-02-03 | Univ Nottingham | Cancer detection method and reagents |
US7807810B2 (en) | 1999-04-08 | 2010-10-05 | The Ohio State University Research Foundation | Nucleic acids encoding the major outer membrane protein of the causative agent of human granulocytic ehrlichiosis and peptides encoded thereby |
US6645465B2 (en) | 1999-08-06 | 2003-11-11 | Michigan, University Of The Regents | Annexin proteins and autoantibodies as serum markers for cancer |
US20020064801A1 (en) * | 1999-12-01 | 2002-05-30 | Ryan Jeffrey R. | Novel and practical serological assay for the clinical diagnosis of leishmaniasis |
US6667160B2 (en) | 2000-03-15 | 2003-12-23 | Kenneth D. Fine | Method for diagnosing immunologic food sensitivity |
US20030232399A1 (en) | 2000-06-14 | 2003-12-18 | Robertson John Forsyth Russell | Cancer detection methods and reagents |
US20030138860A1 (en) | 2000-06-14 | 2003-07-24 | Robertson John Forsyth Russell | Cancer detection methods and reagents |
CA2431201A1 (en) | 2000-12-13 | 2002-08-01 | Bio-Rad Laboratories, Inc. | Standard diluent for multiplex assays |
WO2003073101A2 (en) | 2001-06-21 | 2003-09-04 | New York University | Mycobacterial proteins as early antigens for serodiagnosis and vaccines |
GB0128583D0 (en) * | 2001-11-28 | 2002-01-23 | Rsr Ltd | Detection of autoantibodies indicative of diabetes |
US20030049692A1 (en) * | 2002-09-16 | 2003-03-13 | Norman Latov | Detection of anti-glycolipid antibodies by latex agglutination assay |
GB2424273B (en) * | 2002-11-14 | 2007-06-27 | Univ Nottingham | Method for preparing tumour marker protein |
CN1547025A (zh) * | 2003-12-03 | 2004-11-17 | 刘春杰 | 高灵敏度酶联免疫分析检测试剂盒 |
JP2005352771A (ja) | 2004-06-10 | 2005-12-22 | Hitachi Software Eng Co Ltd | 発現プロファイルによるパターン認識システム |
US20060141547A1 (en) | 2004-11-16 | 2006-06-29 | Das Hasi R | Novel diagnostic marker, a diagnostic kit and a method for diagnosis of rheumatoid arthritis |
GB2426581A (en) | 2005-05-27 | 2006-11-29 | Univ Nottingham | Immunoassay methods |
EP1789435B1 (en) | 2005-09-12 | 2010-02-24 | Industry Foundation of Chonnam National University | A method for production of mature natural killer cell |
TWI304443B (en) | 2005-12-30 | 2008-12-21 | Nat Health Research Institutes | Alpha-enolase specific antibody and method of use |
CN101632020B (zh) | 2006-09-13 | 2013-11-27 | 昂西免疫有限公司 | 改进的免疫测定方法 |
JP5495159B2 (ja) | 2006-09-13 | 2014-05-21 | オンクイミューン リミテッド | 改善されたイムノアッセイ法 |
GB0725239D0 (en) | 2007-12-24 | 2008-02-06 | Oncimmune Ltd | Calibrator for autoantibody assay |
-
2005
- 2005-05-27 GB GB0510943A patent/GB2426581A/en not_active Withdrawn
-
2006
- 2006-05-26 ES ES06744011T patent/ES2328171T3/es active Active
- 2006-05-26 RU RU2007149281/15A patent/RU2416095C2/ru active
- 2006-05-26 DK DK06744011T patent/DK1889059T3/da active
- 2006-05-26 ES ES09004778T patent/ES2384935T3/es active Active
- 2006-05-26 DK DK09004778.8T patent/DK2073008T3/da active
- 2006-05-26 DK DK10180756.8T patent/DK2275815T3/da active
- 2006-05-26 CN CN201210248279.6A patent/CN102749447B/zh active Active
- 2006-05-26 PT PT101807568T patent/PT2275815E/pt unknown
- 2006-05-26 SI SI200631356T patent/SI2073008T1/sl unknown
- 2006-05-26 AT AT06744011T patent/ATE436018T1/de active
- 2006-05-26 CA CA2609793A patent/CA2609793C/en not_active Expired - Fee Related
- 2006-05-26 PL PL06744011T patent/PL1889059T3/pl unknown
- 2006-05-26 EP EP09004778A patent/EP2073008B1/en active Active
- 2006-05-26 PL PL09004778T patent/PL2073008T3/pl unknown
- 2006-05-26 DE DE602006007703T patent/DE602006007703D1/de active Active
- 2006-05-26 US US11/814,516 patent/US8722339B2/en active Active
- 2006-05-26 EP EP10180756.8A patent/EP2275815B1/en active Active
- 2006-05-26 AT AT09004778T patent/ATE554386T1/de active
- 2006-05-26 AU AU2006250923A patent/AU2006250923B2/en not_active Ceased
- 2006-05-26 EP EP06744011A patent/EP1889059B1/en active Active
- 2006-05-26 JP JP2008512924A patent/JP4876127B2/ja active Active
- 2006-05-26 WO PCT/GB2006/001944 patent/WO2006126008A2/en active Application Filing
- 2006-05-26 CN CN200680018335.XA patent/CN101203756B/zh active Active
- 2006-05-26 PT PT09004778T patent/PT2073008E/pt unknown
- 2006-05-26 ES ES10180756.8T patent/ES2458105T3/es active Active
- 2006-05-26 KR KR1020077030551A patent/KR101400986B1/ko active IP Right Grant
- 2006-05-26 MX MX2007014815A patent/MX2007014815A/es active IP Right Grant
-
2007
- 2007-12-27 NO NO20076656A patent/NO339224B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2275815T3 (da) | Forbedrede immunoassay-fremgangsmåder | |
BRPI0707645B8 (pt) | métodos in vitro para detecção de câncer em um indivíduo e para avaliação de prognóstico de um indivíduo tendo, ou suspeito de ter, câncer ovariano | |
BRPI0509419A (pt) | método de ensaio imunossorvente ligado por enzimas, anticorpos, hibridoma e kit de imunoensaio | |
ES2484142T3 (es) | Diagnóstico molecular y clasificación del melanoma maligno | |
ATE476657T1 (de) | Vorhersage von letalität und detektion von schweren erkrankungen | |
ATE438853T1 (de) | Diagnostische testvorrichtung | |
WO2008135564A3 (en) | Assays | |
BRPI0610092B8 (pt) | métodos para a detecção de um analito e de um ácido nucleico em uma amostra, e de sintetização de uma molécula de ácido nucleico ou de análogo de ácido nucleico, kit reagente, uso do mesmo, molécula de ácido nucleico ou de análogo de ácido nucleico e produto associado | |
ATE360809T1 (de) | Schnelltest für biologische substanzen mittels ftir | |
DE602006021777D1 (de) | Diagnoseverfahren für präeklampsie | |
EP1930445A4 (en) | KIT AND METHOD FOR DETECTING UROTHELIAL CANCER | |
DE602006014581D1 (de) | Turbidimetrischer immunoassay zur beurteilung von humanem cystatin c | |
ATE538382T1 (de) | Sequentieller optischer nachweis von einem array mit getrenntentestzonen | |
NZ592819A (en) | Thyroid analyte detection and measurement | |
ATE475096T1 (de) | Unterscheidung zwischen baktiereller meningitis und viraler meningitis | |
DE602005013430D1 (de) | Verwendung von asc als marker für kolorektalkarzinome | |
ATE555385T1 (de) | N1,n12-diacetylspermin als tumormarker | |
DE602005010548D1 (de) | Verbessertes verfahren zur diagnose des akuten koronarsyndroms | |
CY1109461T1 (el) | Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου | |
EP2444812A3 (en) | Improved immunoassay methods | |
ATE534037T1 (de) | Verwendung des proteins asc als marker für brustkrebs | |
WO2004085669A3 (en) | Identification and quantification of microbial species in a sample | |
CY1115323T1 (el) | Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου | |
HRP20200476T1 (hr) | Prognostički postupak i pribor koristan za navedeni postupak | |
Lin et al. | Next-generation confirmatory disease diagnostics |